Showing results (71-80 of 529) with videos related to

Sort By:
Pageof 53
European Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2019
Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of CardiologyIvana Hollan, Nicoletta Ronda, Patrick Dessein, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 7, 2019
Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugsChun-Li Wang, Victor Chien-Chia Wu, Kuo-Hsuan Chang, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2017
Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registryJudit Papp, Endre Zima, Ramon Bover, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 25, 2019
Effectiveness and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and coronary or peripheral artery diseaseCraig I Coleman, William L Baker, Anna-Katharina Meinecke, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|February 1, 2023
LDL lowering effect of PCSK9 inhibition is reduced in womenVeronika A Myasoedova, Antoine Rimbert, Marina Camera, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 24, 2023
Impact of the antiplatelet strategy following patent foramen ovale percutaneous closurePaul Guedeney, Julio I Farjat-Pasos, Gabriel Asslo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smokingMichael Miller, Deepak L Bhatt, Ph Gabriel Steg, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 30, 2021
Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysisAnne H Tavenier, Roxana Mehran, Mauro Chiarito, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 31, 2021
Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular PharmacotherapyEmma F Magavern, Juan Carlos Kaski, Richard M Turner, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 31, 2023
Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registryPeter Moritz Becher, Gianluigi Savarese, Lina Benson, et al.
Pageof 53